Wednesday, Immutep Limited (NASDAQ:IMMP) released preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial evaluating eftilagimod alpha (efti) in combination with Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma patients (1L HNSCC) with negative PD-L1 expression. The investigational immuno-oncology combination demonstrates an overall response rate (ORR) of 26.9% and diseas
Last month, The Bezos Earth Fund announced a $60 million commitment to establish the Bezos Centers for Sustainable Protein, which will focus on the creation of alternative proteins, supporting its mission of supporting farmers and expanding food production in a sustainable way. "We need to feed 10 billion people with healthy, sustainable food throughout this century while protecting our planet. We can do it, and it will require a ton of innovation," Bezos Earth Fund Vice Chair Lauren Sánchez sai
Caterpillar earnings are due early Thursday, The economic bellwether and Dow Jones earthmoving giant has been killing it lately.
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|
Symbol | Letzter Preis | Änderung | % Schwankung |
---|---|---|---|